AbbVie (ABBV) Earnings Date, Estimates & Call Transcripts $192.32 -2.68 (-1.37%) Closing price 07/11/2025 03:59 PM EasternExtended Trading$192.38 +0.06 (+0.03%) As of 07/11/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AbbVie Earnings Summary AbbVie announced Q1 2025 earnings on April 25, 2025, reporting an EPS of $2.46, which beat analysts' consensus estimates of $2.40 by $0.06. Quarterly revenue rose 8.4% year-over-year to $13.34 billion, above analyst estimates of $12.91 billion. With a trailing EPS of $2.35 and a P/E Ratio of 81.84, AbbVie's earnings are expected to grow 13.57% next year, from $12.31 to $13.98 per share. Upcoming Q2 Earnings DateJul. 31Before Market OpensEstimatedConsensus EPS (Apr. 25) $2.40 Actual EPS (Apr. 25) $2.46 Beat By $0.06 Actual Revenue (Apr. 25) $13.34BQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)ABBV Upcoming EarningsAbbVie's Q2 2025 earnings is scheduled for Thursday, July 31, 2025, with a conference call scheduled at 9:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get AbbVie Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AbbVie and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataABBV Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ABBV Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AbbVie Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue GuidanceQ1 20253$2.37$2.42$2.392.340 - 2.380 - Q2 20253$2.87$3.37$3.102.840 - 2.880 - Q3 20253$3.02$3.20$3.13Q4 20253$3.27$3.39$3.33 FY 2025 12 $11.53 $12.38 $11.95 Q1 20261$2.88$2.88$2.88Q2 20261$3.33$3.33$3.33Q3 20261$3.63$3.63$3.63Q4 20261$3.80$3.80$3.80 AbbVie Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/31/2025(Estimated)-------4/25/2025Q1 2025$2.40$2.46+$0.06$0.72$12.91B$13.34B1/31/2025Q4 2024$2.98$2.16 -$0.82-$0.02$14.81B-10/30/2024Q3 2024$2.92$3.00+$0.08$5.12$14.28B$14.46B7/25/2024Q2 2024$2.57$2.65+$0.08$4.53$14.02B$14.46B5/3/2024Q1 2024$2.26$2.31+$0.05$3.85$11.93B$12.31B2/2/2024Q4 2023$2.76$2.79+$0.03$5.12$14.02B$14.30B10/27/2023Q3 2023$2.86$2.95+$0.09$4.90$13.72B$13.93B7/27/2023Q2 2023$2.79$2.91+$0.12$4.68$13.52B$13.87B AbbVie Earnings - Frequently Asked Questions When is AbbVie's earnings date? AbbVie has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, July 31st, 2025 based off last year's report dates. Learn more on ABBV's earnings history. What guidance has AbbVie issued on next quarter's earnings? AbbVie issued an update on its FY 2025 earnings guidance on Monday, July, 7th. The company provided EPS guidance of 11.670-11.870 for the period. The company issued revenue guidance of -. Did AbbVie beat their earnings estimates last quarter? In the previous quarter, AbbVie (NYSE:ABBV) reported $2.46 earnings per share (EPS) to beat the analysts' consensus estimate of $2.40 by $0.06. Learn more on analysts' earnings estimate vs. ABBV's actual earnings. How can I listen to AbbVie's earnings conference call? The conference call for AbbVie's latest earnings report can be listened to online. Listen to Conference Call How can I read AbbVie's conference call transcript? The conference call transcript for AbbVie's latest earnings report can be read online. Read Transcript How much revenue does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded annual revenue of $56.33 billion. How much profit does AbbVie generate each year? AbbVie (NYSE:ABBV) has a recorded net income of $4.28 billion. ABBV has generated $2.35 earnings per share over the last four quarters. What is AbbVie's price-to-earnings ratio? AbbVie (NYSE:ABBV) has a trailing price-to-earnings ratio of 81.84 and a forward price-to-earnings ratio of 15.62. The price/earnings-to-growth ratio is 1.28. What is AbbVie's EPS forecast for next year? AbbVie's earnings are expected to grow from $12.31 per share to $13.98 per share in the next year, which is a 13.57% increase. More Earnings Resources from MarketBeat Related Companies Amgen Earnings Results Gilead Sciences Earnings Results Moderna Earnings Results Abbott Laboratories Earnings Results Bristol Myers Squibb Earnings Results Johnson & Johnson Earnings Results Eli Lilly and Company Earnings Results Merck & Co., Inc. Earnings Results Pfizer Earnings Results Zoetis Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs This page (NYSE:ABBV) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AbbVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AbbVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABBV Stock Alerts